April 2020 – Page 2 – Market Research Insights

Epigenetics Diagnostic Market Projected To Expand At A CAGR 18.8% For The Forecast Period From 2019 To 2026: Grand View Research Inc.

San Francisco, 29 April 2020: The Report Epigenetics Diagnostic Market Size, Share & Trends Analysis Report By Technology, By Product (Reagents, Kits, Instruments), By Application (Oncology, Non-oncology), By Region, And Segment Forecasts, 2019 – 2026

The global epigenetics diagnostic market size is expected to reach USD 21.7 billion by 2026, expanding at a CAGR of 18.8% over the forecast period, according to a new study by Grand View Research, Inc. Growing prevalence of cancer and other diseases across the globe, along with epigenetic modification base, is anticipated to fuel the industry growth during the forecast period.

Diagnostic companies are upgrading their products by implementing new techniques for attaining specific and sensitive results. Companies such as Abcam plc, Invitrogen, and Sigma Aldrich Corporation are developing a new range of Chromatin immunoprecipitation (ChIP)-validated antibodies specific for detection of histone modifications at various loci.

In addition, many biotechnology and pharmaceutical companies and academic research organizations are collaborating to promote the growth of the epigenetics diagnostic industry. Companies such as Epigenomics, OncoMethylome Sciences, and Orion Genomics have collaborated with other laboratories and diagnostic companies that have licensed their technology for development of Laboratory-developed Tests (LDTs).

Technological advancements resulting in increased accuracy, portability, and cost-effectiveness are expected to be a high-impact rendering driver in the market. For instance, Diagenode has developed automated kits for detection and purification of methylated DNA.

Access Research Report of Epigenetics Diagnostic Market @ https://www.grandviewresearch.com/industry-analysis/epigenetics-diagnostic-market

Further key findings from the study suggest:

On the basis of product, reagents held the largest share owing to increasing R&D activities in field of epigenetics. Kits are expected to witness high demand over the forecast period, expanding at a CAGR of 19.2% due to need for rapid and accurate detection techniques
Based on technology, DNA methylation held a major share in terms of revenue in 2018. Technological advancements such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are the factors attributing to its largest share
Growing prevalence of cancer with epigenetic modification is a key factor driving the oncology application segment. Solid tumors further dominated the segment in 2018
North America emerged as a major regional market in 2018 due to factors such as high levels of patient awareness, growing collaborations between large pharmaceutical firms for development of improved therapeutics, increasing funding for R&D, and increasing cancer prevalence
The market in Asia Pacific is estimated to witness significant growth over the forecast period with a CAGR of 20.9% owing to the presence of large target population having cancer, diabetes, and other chronic disorders, along with parallel unmet clinical needs
Major players of the industry include Sigma-Aldrich Corporation; Valirx Plc; Oncolys Biopharma Inc.; Zymo Research Corporation; Qiagen; Thermo Fisher Scientific; Diagenode Diagnostics; and Illumina, Inc. Extensive R&D initiatives for development of novel drugs and presence of strong product pipeline are expected to further boost the market growth over the forecast period.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global epigenetics diagnostic market on the basis of product, technology, application, and region:

Epigenetics Diagnostic Product Outlook (Revenue, USD Million, 2014 – 2026)

Reagents
Kits
- ChIP Sequencing Kit
- Whole Genomic Amplification Kit
- Bisulfite Conversion Kit
- RNA Sequencing Kit
- Others
Instruments
Enzymes
Services

Epigenetics Diagnostic Technology Outlook (Revenue, USD Million, 2014 – 2026)

DNA Methylation
- Reagents
- Kits
- Instruments
- Enzymes
- Services
Histone Methylation
- Reagents
- Kits
- Instruments
- Enzymes
- Services
Histone Acetylation
- Reagents
- Kits
- Instruments
- Enzymes
- Services
Large non-coding RNA
- Reagents
- Kits
- Instruments
- Enzymes
- Services
MicroRNA modification
- Reagents
- Kits
- Instruments
- Enzymes
- Services
Chromatin structures
- Reagents
- Kits
- Instruments
- Enzymes
- Services

Epigenetics Diagnostic Application Outlook (Revenue, USD Million, 2014 – 2026)

Oncology
- Solid tumors
- Liquid tumors
Non-oncology
- Inflammatory diseases
- Metabolic diseases
- Infectious diseases
- Cardiovascular diseases
- Others

Epigenetics Diagnostic Regional Outlook (Revenue, USD Million, 2014 – 2026)

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Access Press Release of Epigenetics Diagnostic Market @ https://www.grandviewresearch.com/press-release/global-epigenetics-diagnostic-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Idiopathic Pulmonary Fibrosis Treatment Market Size To Hit USD 5.2 Billion By 2026: Grand View Research Inc.

San Francisco, 29 April 2020: The Report Idiopathic Pulmonary Fibrosis Treatment Market Size, Share & Trends Analysis Report By Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), By Region, And Segment Forecasts, 2019 – 2026

The global idiopathic pulmonary fibrosis (IPF) treatment market size is expected to reach a value of USD 5.2 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 12.7% during the forecast period. Increasing R&D initiatives undertaken by companies and surge in cigarette smoking population are anticipated to boost the growth.

Rise in the initiatives undertaken by manufacturers to develop products with novel mechanisms is anticipated to fuel the IPF treatment market growth. For instance, FibroGen, Inc., is currently developing a drug, pamrevlumab – a monoclonal antibody that targets the connective tissue growth factor. The phase III trials of pamrevlumab are expected to be initiated in the first half of 2019. The drug has received fast track designation from the Food and Drug Administration (FDA).

An aging population can be expected to have far-reaching social, economic, and political implications on nearly all the sectors including the healthcare sector. An associated consequence of an increase in the geriatric population will be an increase in the incidences of various medical conditions requiring long-term care. Moreover, the growing geriatric population base in countries with large untapped opportunities such as China and Japan is anticipated to drive the market growth during the forecast period.

The dramatic increase in cigarette smoking population is one of the major drivers likely to have a positive impact on market growth. According to the U.S. FDA and Centers for Disease Control and Prevention (CDC), in 2018, more than 3.6 million high and middle school students were existing e-cigarette users. The number increased by 1.5 million since the last year. The uptake in the use of e-cigarette is expected to lead to the incidence of IPF.

Access Research Report of Idiopathic Pulmonary Fibrosis Treatment Market @ https://www.grandviewresearch.com/industry-analysis/idiopathic-pulmonary-fibrosis-ipf-treatment-market

Further key findings from the study suggest:

MAPK Inhibitors segment held the largest market share in 2018. Esbriet is the first drug approved for the treatment of IPF
Tyrosine kinase inhibitor is the second largest segment and is expected to expand at a CAGR of 11.0%
Autotaxin inhibitors (GLPG1690) is expected to post lucrative CAGR. GLPG1690 is currently in phase III trial and is expected to be commercialized in 2022
S. led in 2018 due to high market penetration and high awareness pertaining to IPF
IPF treatment market in Japan is estimated to decline over the forecast period owing to patent expiry of Esbriet in 2018
Some of the major players operating in the Idiopathic Pulmonary Fibrosis treatment market are F. Hoffman La-Roche Ltd; Boehringer Ingelheim International GmbH; Galapagos; FibroGen, Inc.; Prometic Life Sciences Inc.; Bristol-Myers Squibb Company; MediciNova, Inc.; Merck & Co., Inc.; Novartis AG; and Merck & Co.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Idiopathic Pulmonary Fibrosis treatment market by drug class and region:

Idiopathic Pulmonary Fibrosis (IPF) Drug Class Outlook (Revenue, USD Million, 2014 – 2026)

MAPK Inhibitors
- Esbriet
Tyrosine Inhibitors
- Ofev
Autotaxin Inhibitors
- GLPG 1690

Idiopathic Pulmonary Fibrosis (IPF) Treatment Regional Outlook (Revenue, USD Million, 2014 – 2026)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Idiopathic Pulmonary Fibrosis Treatment Market @ https://www.grandviewresearch.com/press-release/global-idiopathic-pulmonary-fibrosis-ipf-treatment-market

About Grand View Research

For More Information:www.grandviewresearch.com

Digital Twin Market Expanding At A CAGR Of 38.2% For The Forecast Period From 2018 To 2025: Grand View Research Inc.

San Francisco, 29 April 2020: The Report Digital Twin Market Size, Share & Trends Analysis Report By End Use (Automotive & Transport, Retail & Consumer Goods, Agriculture), By Region (Europe, North America, Asia Pacific), And Segment Forecasts, 2018 – 2025

The global digital twin market size is expected to reach USD 26.07 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to register a strong CAGR of 38.2% over the forecast years. Digital twin is a dynamic digital replica of a product, process, system, or facility, which can be used for various purposes including creating a sustainable environment and ensuring a better digital experience for customers. Such digital replicas can imitate real-world situations and help in optimizing systems and processes, examining products, and monitoring the performance and condition of machines, among others.

The digital twin technology is gaining traction owing to its potential to bridge the gap between the physical world and virtual world. The global market is expected to grow significantly over the forecast period in line with the growing adoption of Internet of Things (IoT) and big data analytics. Other factors responsible for this growth include rising need for cost-efficient operations, optimizing the processes, and reducing the Time to Market (TTM). At the same time, the way digital twins are created would continue to evolve in line with the innovations in the field of Virtual Reality (VR) and Augmented Reality (AR), thereby boosting the growth of the market.

Healthcare and life sciences, aerospace and defense, automotive and transport, manufacturing, and energy and utilities are some of the key end-use industries for the digital twin technology. Incumbents of these industries are particularly adopting the technology to enhance efficiency, augment productivity, ensure cost-efficient operations, and streamline the processes. For instance, hospitals can create a digital twin of their systems as part of the efforts to gauge the impact of any prospective changes to their systems and ensure a safer environment. Similarly, a surgeon can create a digital twin of the heart and study it before performing a surgery. The technology is also helping companies in adopting lean manufacturing.

Access Research Report of Digital Twin Market @ https://www.grandviewresearch.com/industry-analysis/digital-twin-market

Further key findings from the study suggest:

Growing adoption of the digital twin technology in various industries, such as automotive and transport and agriculture, is the major growth-driving factor for the global market
Digital twin incorporates Artificial Intelligence (AI), big data, Machine Learning (ML), and IoT, among others
This helps the end-use industries in accessing the technology more easily and implementing it cost-effectively, thereby supporting market growth
The manufacturing segment accounted for more than 20.0% of the global market share in 2017 and is expected to witness a strong CAGR over the forecast period
North America and Europe together accounted for more than 50% of the market share in 2017 on account of high adoption of industrial IoT and presence of developed infrastructure in these regions
Prominent companies in the digital twin market include ABB Group; Hexagon Geosystems AG; PTC, Inc.; Dassault Systèmes; AVEVA Group plc; SAP SE; Schneider Electric SE; and Siemens AG. Most of these companies are investing in R&D to maintain their position in the global market

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global digital twin market on the basis of end use and region:

Digital Twin End-use Outlook (Revenue, USD Million, 2014 – 2025)

Manufacturing
Agriculture
Automotive & Transport
Energy & Utilities
Healthcare & Life Sciences
Residential & Commercial
Retail & Consumer Goods
Others

Digital Twin Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Access Press Release of Digital Twin Market @ https://www.grandviewresearch.com/press-release/global-digital-twin-market

About Grand View Research

For More Information:www.grandviewresearch.com

Electric Vehicle Range Extender Market Demand To Reach 494,083 Units By 2025: Grand View Research Inc.

San Francisco, 29 April 2020: The Report Electric Vehicle (EV) Range Extender Market Size, Share & Trends Analysis Report By Product, By Vehicle (Passenger, Commercial), By Component (Battery Pack, Power Converter), And Segment Forecasts, 2018 – 2025

The global EV range extender market demand is estimated to reach 494,083 units by 2025 at a 10.2% CAGR during the forecast period, according to a new report by Grand View Research, Inc. An electric vehicle (EV) range extender is an external system that helps increase vehicle range to support long-distance travel. Robust growth in adoption of fully electric passenger and commercial vehicles to reduce CO₂ emissions, coupled with extendable range and high-performance capabilities, are expected to propel market growth.

The automotive industry is considered to be the largest consumer of oil in the world, contributing to high pollution levels globally. Governments across various countries have imposed stringent regulations on automobile manufacturers to produce low/zero emission vehicles to help reduce carbon footprint.

Besides this, governments of developing countries such as China and India are providing subsidies to promote the adoption of electric vehicles. For instance, in August 2018, the Indian government announced to offer a subsidy of around 20% on purchase of new electric vehicles. However, low mileage range of EVs can be a major concern for consumers as it limits the distance traveled. To overcome this, key manufacturers such as BMW Group, General Motors, Volvo Car Corp., and Mahle Group have launched EV range extender solutions that help increase battery capacity to support long distance traveling. This has had a positive impact on market growth.

In an attempt to increase their market share and improve overall profitability, key automobile manufacturers are focused on integrating range extenders into their new EV models. For instance, BMW Group launched the BMW i3 EV integrated with a range extender solution, which enables consumers to drive longer distances. In 2016, Nissan Motors Co. Ltd. launched LEAF, an e-powered hybrid vehicle, in several APAC countries.

Key market players are also investing significant funds in R&D activities to develop innovative range extender products to extend driving range and improve battery efficiency, along with reducing overall battery price. However, increasing focus of OEMs to incorporate range extender technology in upcoming EV models, coupled with increasing trade conflicts between China and U.S., may hinder market growth over the forecast period.

Access Research Report of Electric Vehicle Range Extender Market @ https://www.grandviewresearch.com/industry-analysis/electric-vehicle-ev-range-extender-market

Further key findings from the study suggest that:

North America accounted for the largest market share in 2017. The regional market will witness growth with some large market players such as General Motors Co. and Magna International Inc. offering ICE and fuel cell range extenders
European governments are actively offering several rebates and subsidies to boost adoption of EVs. However, there is a lack of charging infrastructure as against rising EV sales, which is expected to propel demand for EV range extenders
Governments across the globe are continuously investing in enhancing public transport infrastructure, thereby driving adoption of electric commercial vehicles. Deployment cost of range extenders is lower than the cost involved in setting up a charging infrastructure
Key market players are collaborating with EV manufacturers to develop new innovative technologies that will offer alternative range extender solutions as well as incorporate range extenders in new vehicle models.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/automotive-and-transportation

Grand View Research has segmented the global EV range extender market on the basis of product, vehicle, component, and region:

EV Range Extender Product Outlook (Volume, Units, 2015 – 2025)

ICE range extender
Fuel cell range extender
Others

EV Range Extender Vehicle Outlook (Volume, Units, 2015 – 2025)

Passenger vehicles
Commercial vehicles

EV Range Extender Component Outlook (Volume, Units, 2015 – 2025)

Battery pack
Generator
Power converter
Electric motor

EV Range Extender Regional Outlook (Volume, Units, 2015 – 2025)

North America
Europe
Asia Pacific

Access Press Release of Electric Vehicle Range Extender Market @ https://www.grandviewresearch.com/press-release/global-electric-vehicle-ev-range-extender-market

About Grand View Research

For More Information:www.grandviewresearch.com

Smart Robots Market Expanding At A CAGR Of 22.4% For The Forecast Period From 2018 To 2025: Grand View Research Inc.

San Francisco, 29 April 2020: The Report Smart Robots Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Service), By Application, By End Use (Industrial, Commercial, Residential), By Vertical, By Region, And Segment Forecasts, 2018 – 2025

The global smart robots market size is anticipated to reach USD 16.46 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 22.4% over the forecast period. Factors such as increasing adoption of autonomous robots for carrying out iterative tasks, rapid technological developments in robotics, and increasing investments in industrial automation have boosted the adoption of smart robots in various end use segments.

Smart robots are commonly used for performing various tasks in field applications, metal fabrication, packaging and palletizing, among others. These robots perform tasks independently as well as can work with humans in various manufacturing and maintenance operations. Smart robots are widely used in industries such as automotive and manufacturing to enhance productivity and to reduce labor cost. In addition, benefits such as minimal accidents and higher accuracy are driving the market growth.

The introduction of smart collaborative robots and Artificial Intelligence (AI) enabled systems with enhanced reliability and accuracy is expected to drive growth of the smart robots market over the forecast period. Numerous companies such as Fanuc Corporation, ABB Ltd., and Yaskawa Electric Corporation, among others, are implementing advanced robotics technologies for versatile end-use applications. This factor is anticipated to further boost the market expansion in the forthcoming years.

The industrial robot segment is anticipated to witness substantial growth in near future owing to their wide adoption in process automation in various industries. Increasing investment in industrial automation has boosted the adoption of smart robots among packaging, manufacturing, and material handling among other industries. Moreover, rising adoption of Internet of Things (IoT) and Artificial Intelligence (AI) has also encouraged end users to implement the smart robotics technology.

The market for smart robots is expected to witness volatility owing to mergers and acquisitions, high competition, and presence of new as well as well-established participants. In August 2016, Panasonic Corporation acquired OpenSynergy GmbH, a German software company. OpenSynergy is a high-tech company specializing in embedded automotive software for cockpit solutions. This acquisition is expected to enhance its business in the automotive sector.

Access Research Report of Smart Robots Market @ https://www.grandviewresearch.com/industry-analysis/smart-robots-market

Further key findings from the study suggest:

Demand for smart robots has increased over the years owing to benefits such as automation, safety, cost reduction, and reliability
Governments across the globe are promoting industrial automation to improve productivity
The Asia Pacific region is projected to witness remarkable growth over the forecast period owing to increasing application of smart robots in manufacturing and automotive industries
The market is expected to grow at exponential pace as numerous diverse applications come to light and different types of niche products including application specific robots are commercialized
Key players in the smart robots market include ABB Ltd., Kuka AG, iRobot Corporation, and Fanuc Corporation, among others.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global smart robots market based on component, application, end use, vertical, and region:

Smart Robots Component Outlook (Revenue, USD Million, 2014 – 2025)

Hardware
Software
Service

Smart Robots Application Outlook (Revenue, USD Million, 2014 – 2025)

Industrial Robots
- Field Applications
- Metal Fabrication
- Packaging and Palletizing
- Others
Service Robots
- Mobility
- Security & Inspection
- Healthcare Applications
- Others

Smart Robots End Use Outlook (Revenue, USD Million, 2014 – 2025)

Industrial
Commercial
Residential

Smart Robots Vertical Outlook (Revenue, USD Million, 2014 – 2025)

Automotive
Healthcare
Manufacturing
Food & Beverages
Retail
Energy & Utility
Others

Smart Robots Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
South America
Middle East & Africa

Access Press Release of Smart Robots Market @ https://www.grandviewresearch.com/press-release/global-smart-robots-market

About Grand View Research

For More Information:www.grandviewresearch.com

Voice And Speech Recognition Software Market Size Is Likely To Reach USD 31.82 Billion By 2025: Grand View Research Inc.

San Francisco, 29 April 2020: The Report Voice And Speech Recognition Software Market Size, Share & Trends Analysis Report, By Function, By Technology (AI-based, Non-AI Based), By Vertical (Consumer, Automotive), And Segment Forecasts, 2019 – 2025

The global voice and speech recognition software market size is anticipated to reach USD 31.82 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 17.5% during the forecast period. The market is anticipated to witness an upsurge in the adoption of voice activated systems, voice-enabled devices, and voice-enabled virtual assistant systems owing to the rising application in the banking and automobile sectors. The escalating need to counter fraudulent activities and to enhance security in the banking sector is projected to boost the adoption of voice biometrics for user authentication.

Automobile sector is expected to gain momentum owing to advancements in technology and emergence of innovative concepts such as autonomous and connected cars. Integration of voice-activated software in future cars is anticipated to drive demand for technologies such as noise abatement for selectively ignoring driving and passenger noises for providing an error-free and seamless experience to the operator.

Voice recognition is also a core technology widely used in healthcare sector to enhance the Electronic Health Record (EHR) systems by providing an ease to the doctor to speak and keep the records instead of manual typing or writing. In 2018, the healthcare vertical held the largest market share and is expected to grow significantly over the forecast period.

Artificial Intelligence (AI)-based voice and speech recognition software is expected to expand at a high CAGR owing to the continuous development of machine learning techniques and integration of connected devices with personal assistants. For instance, Dragon Drive is a personal assistant developed by Nuance Communication Inc. that integrates various household appliances, cars, and smartphones that can be connected to a hub through the internet. Thus, an individual can get alerts about daily chores, work schedules, traffic updates, and many more alerts through the Dragon Drive.

However, the lack of accuracy of these technologies in recognizing the regional accents and dialects is expected to limit the growth of the voice and speech recognition software market. Additionally, sentiment analysis using the changes in the pitch of the voice is anticipated to provide growth opportunity to the market in the forthcoming years.

Access Research Report of Voice And Speech Recognition Software Market @ https://www.grandviewresearch.com/industry-analysis/voice-speech-recognition-software-market

Further key findings from the report suggest:

Rising trend in development of artificial intelligence-based system is expected to be the key factor driving the market over the forecast period. Leveraging deep learning algorithm in voice and speech solutions for better search results is expected to be the key growth driver for AI-based technology segment
Deployment of speech recognition solutions in consumer and retail verticals is anticipated to lead to the high market growth, attributed to the changing lifestyle in several countries including U.S., Germany, and U.K. Growing adoption of smart electronics in India, China, Japan, and Brazil is also likely to drive growth in consumer vertical
North America led the market, in terms of revenue, representing over 36% of the total market share in 2018. Additionally, North America and Asia Pacific are anticipated to witness a considerable growth owing to the presence of several U.S.- and China-based players, such as Apple, Inc.; Facebook, Inc.; Baidu, Inc.; Amazon.com, Inc.; and Alphabet, Inc.; working toward the development of this technology
Key companies operating in the voice and speech recognition software market include Advanced Voice Recognition Systems, Inc.; Agnitio S.L.; Amazon.com, Inc.; Api.ai; Apple, Inc.; Anhui USTC iFlytek o., Ltd.; Baidu, Inc.; BioTrust ID B.V.; CastleOS Software, LLC; Facebook, Inc.; Google, Inc.; International Business Machines Corporation; JStar; LumenVox LLC; M2SYSLLC; Microsoft Corporation; MModal, Inc.; Nortek Holdings, Inc.; Nuance Communications, Inc.; Raytheon Company; SemVox GmbH; Sensory, Inc.; ValidSoft UK Limited; VoiceBox Technologies Corporation; and VoiceVault, Inc. These players focus on integrating the artificial intelligence technology, to build superior products that would increase their user customer base.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global voice and speech recognition software market report based on function, technology, vertical, and region.

Voice and Speech Recognition Software Function Outlook (Revenue, USD Million, 2014 – 2025)

Voice Recognition
- Speaker Verification
- Speech Recognition
Speaker Identification
- Automatic Speech Recognition
- Text to Speech

Voice and Speech Recognition Software Technology Outlook (Revenue, USD Million, 2014 – 2025)

AI-based
Non-AI based

Voice and Speech Recognition Software Vertical Outlook (Revenue, USD Million, 2014 – 2025)

Automotive
BFSI
Consumer
Education
Enterprise
Government
Healthcare
Legal
Military
Retail
Others

Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
South America
Middle East and Africa

Access Press Release of Voice And Speech Recognition Software Market @ https://www.grandviewresearch.com/press-release/global-voice-speech-recognition-software-market

About Grand View Research

For More Information:www.grandviewresearch.com

Glucose Biosensors Market Size Is Projected To Reach USD 31.0 Billion By 2022: Grand View Research Inc.

San Francisco, 28 April 2020: The Report Glucose Biosensor Market Size, Share & Trends Analysis Report By End-use (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, Clinics), By Region (U.S., UK, Germany, China, India, Brazil, Saudi Arabia, South Africa), And Segment Forecasts, 2012 – 2022

Global Glucose Biosensor Market size is expected to reach USD 31.0 billion by 2022, according to a new report by Grand View Research Inc. The global market is anticipated to witness lucrative growth during the period of 2015 to 2022.

Some key factors attributing to the growth of this market include the increasing incidence of diabetes across the globe, development of technologically advanced products, growing demand for minimally and non-invasive products, patient awareness levels, and the need for early diabetes detection. However, presence of other alternatives for management of the diabetes, such as laboratory methods is expected to restrict market growth.

The glucose biosensors industry by end-use is segmented on the basis of its use in hospitals, homecare diagnostics, and others including research institutes, diagnostics, and clinical laboratories. The homecare diagnostics market is projected to flourish over the forecast period. Ease-of-use, quick results, and low costs of the tests are some aspects supporting market growth. On the other hand, the hospital-based market is projected to grow at a significant CAGR of 10.3% during the period 2015 to 2022.

Access Research Report of Glucose Biosensors Market @ https://www.grandviewresearch.com/press-release/global-glucose-biosensor-market

Further key findings from the study suggest:

North America led the market, in terms of value, with a share of about 37% in 2015. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S., has resulted in this country account for a large revenue share of the North American market in 2014. According to the Centers of Disease Control (CDC), around 22.3 million people in the U.S. were estimated to be diagnosed with diabetes in the year 2013.
Asia Pacific is anticipated to witness lucrative growth during the forecast period. This market is projected to grow rapidly during the period 2015 to 2022. China and India are expected to spearhead market growth in this region.
The homecare diagnostics Glucose Biosensors Market was the largest in 2014. The segment is anticipated to grow at a rapid CAGR during the forecast period. As of 2015, the market was led by North America owing to the region’s highest disease burden and homecare diagnostics adoption rates.
The market comprises several local as well as global players. Some major players of this industry include Roche, Bayer and LifeScan, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global Glucose Biosensors Market on the basis of end-user application and region:

Glucose Biosensors End-use Outlook (Revenue, USD Million, 2012 – 2022)

Hospitals
Homecare Diagnostics
Others

Glucose Biosensors Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Glucose Biosensors Market @ https://www.grandviewresearch.com/press-release/global-glucose-biosensor-market

About Grand View Research

For More Information:www.grandviewresearch.com

Capsule Endoscopy Market Expected To Witness A Substantial Growth Of USD 886.3 Million By 2022: Grand View Research Inc.

San Francisco, 28 April 2020: The Report Capsule Endoscopy Market Analysis By Accessory (Wireless Capsule, Workstation & Recorder), By Product (Small Bowel, Esophageal, Colon), By Application (OGIB, Crohn’s, Small Intestine Tumors) And Segment Forecasts To 2022

Global capsule endoscopy market is expected to reach USD 886.3 million by 2022; according to a new study by Grand View Research, Inc. Increasing prevalence of colorectal cancer, GI diseases and growing demand for precise and accurate diagnostic tools are expected to drive the capsule endoscopy market over the forecast period. According to a report published by the World Cancer Research Institute, about 54.0% of colorectal cancer cases occurred in developed countries and the number is expected to grow exponentially over the decade. The introduction of technologically advanced features such as WiFi enabled small bowel capsules featuring longer battery life are further expected to drive the demand for capsule endoscopy devices. Presence of favorable government initiatives are expected to play an imperative role in determining market trends over the forecast period. For instance, initiatives such as the DCPC’s National Comprehensive Cancer Control Program (NCCCP) in the U.S. aimed at increasing patient awareness levels pertaining to colorectal cancer screening is expected to boost usage rates during the forecast period.

Access Research Report of Capsule Endoscopy Market @ https://www.grandviewresearch.com/industry-analysis/capsule-endoscopes-market

Further key findings from the study suggest:

Wireless capsules dominated the accessory market in 2014 and are also expected to register lucrative growth over the forecast period. Increasing usage rates of colon, small intestine and esophageal screening is expected to drive segment growth. In addition, presence of supportive reimbursement policies and the introduction of technologically advanced products are expected to serve this market as future growth opportunities.
Small bowel endoscopy capsule was the leading product segment of the market in 2014. These devices find wide applications in treating diseases such as suspected Crohn’s disease, inflammatory bowel disease, obscure GI tract bleeding and small bowel neoplastic lesions and this is expected to serve the segment as a high impact rendering driver. Increasing prevalence of target diseases is also expected to make significant contributions towards market growth.
Capsule endoscopy finds the largest application in OGIB (Obscure gastrointestinal bleeding) diagnosis owing to, increasing usage of wireless capsule endoscopes in vascular and inflammatory lesion diagnoses
North America was the largest regional capsule endoscopy market in 2014. The region’s market position is attributed to by factors such as presence of sophisticated healthcare infrastructure, supportive reimbursement policies and growing adoption rates of minimally invasive surgeries.
Asia Pacific region is anticipated to register rapid growth over the forecast period owing to, factors such as the presence of high unmet needs with respect to colorectal screening, rising disposable income and patient awareness levels and improving healthcare infrastructure
Key market players of the capsule endoscopy market include RF System lab, Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Given Imaging, Ltd., Fujifilm Holding Corporation, IntroMedic Co., Ltd and CapsoVision.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global capsule endoscopy market on the basis of accessory, product, application and region:

Global Capsule Endoscopy Accessories Outlook (Revenue, USD Million, 2012 – 2022)

Wireless capsule
Workstation and receiver

Global Capsule Endoscopy Product Outlook (Revenue, USD Million, 2012 – 2022)

Small bowel
Esophageal
Colon

Global Capsule Endoscopy Application Outlook (Revenue, USD Million, 2012 – 2022)

OGIB
Crohn’s disease
Small Intestine tumor
Others (Celiac, NSAID reactions)

Capsule Endoscopy Regional Outlook (Revenue, USD Million, 2014 – 2022)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Capsule Endoscopy Market @ https://www.grandviewresearch.com/press-release/global-capsule-endoscopy-market

About Grand View Research

For More Information:www.grandviewresearch.com

Neurology Devices Market Trends, Demand, Production, Analysis and Forecast to 2022 : Grand View Research Inc.

San Francisco, 28 April 2020: The Report Neurology Devices Market Analysis By Product (Neurostimulation, Interventional Neurology, CSF Management, Spinal Cord Stimulation, Deep Brain Stimulation, Embolization, Neurovascular Catheters, Cerebral Angioplasty & Stents, CSF Shunts, Ultrasonic Aspirators, Stereotactic Systems) And Segment Forecasts To 2022

Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.

Rise in incidence of cerebral stroke and other severe disorders such as Alzheimer’s disease, epilepsy, and Parkinsonism is expected to fuel demand of neurology devices thereby driving industry growth. According to National Institute of Neurological Disorders and Stroke (NINDS), approximately 50 million Americans are affected due to these disorders leading to high economic & disease costs burden for medical expenses coupled with loss of productivity. The industry is expected to witness a considerable increase in demand for CNS related therapeutic procedures over the forecast period.

Access Research Report of Neurology Devices Market @ https://www.grandviewresearch.com/industry-analysis/neurology-devices-market

Further key findings from the study suggest:

Neurostimulation devices accounted for over 50% of the revenue generated in the market for 2014. This large share can be attributed to the growing number of chronic CNS disorders, a globally ageing population and development of minimally invasive neurological and faster acting stimulation devices that attract higher market usage and penetration in the neurology devices market.
Neurosurgery segment including ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips are expected to witness considerable growth over the forecast period due to their essential nature of use in tumor removal and brain cell damage repair surgeries.
North America dominated the market in 2014, with revenue estimated at over USD 2,400 million. Presence of sophisticated healthcare infrastructure, favorable government initiatives pertaining to pharmaceutical R&D, cancer research, neurological R&D investment, and the presence of a considerably large CNS disorder patient base are some drivers of this market.
Asia Pacific is expected to witness lucrative CAGR of over 8.0% from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment, and growing medical expenditures in emerging economies such as India and China. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in neuro-informatics and high untapped market opportunities are the important factors accounting for the expected growth of market in this region over the forecast period.
Key participants of the neurology devices market include Johnson and Johnson, B.Braun Melsungen AG, Boston Scientific Corporation, St. Jude Medical Inc Covidien PLC, Medtronic Inc., Johnson & Johnson, Magstim Co Ltd., W.L. Gore & Associates Inc., Integra Life Sciences Holdings Corp., Stryker Corp.
Market participants are involved in R&D for development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, collaborations with university as well as non-university based institutes that are engaged in neuroscience research are expected to boost sector growth in the coming years.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented neurology devices market on the basis of product, method, application, and region:

Global Neurology Devices Product Outlook (Market Revenue in USD Million, 2012 – 2022 )

Neurostimulation
- Spinal Cord Stimulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling and Embolization
  - Embolic Coils
  - Flow Diversion Devices
  - Liquid Embolic Reagents
- Neurovascular Catheters
  - Micro Catheters
  - Micro Guidewires
- Cerebral Balloon Angioplasty &Stents
  - Carotid Artery Stents
  - Filter Devices
  - Balloon Occlusion Devices
- Neurothromobectomy
  - Clot Retrievers
  - Suction Aspiration Devices
  - Snare Devices
- CSF Management Devices
  - Cerebral Shunts
  - Cerebral External Drainage
- Neurosurgery Devices
  - Ultrasonic Aspirators
  - Stereotactic Systems
  - Neuroendoscopes
  - Aneurysm Clips

Global Neurology Devices Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America
Europe
Asia Pacific
RoW

Access Press Release of Neurology Devices Market @ https://www.grandviewresearch.com/press-release/global-neurology-devices-market

About Grand View Research

For More Information:www.grandviewresearch.com

Cardiac Prosthetic Devices Market Size Worth $ 8.7 Billion By 2025: Grand View Research Inc.

San Francisco, 28 April 2020: The Report Cardiac Prosthetic Devices Market Size, Share & Trends Analysis Report By Product (Heart Valves, Mechanical Valve, Tissue Valve, Transcatheter Valve, Pacemakers, Implantable Pacemakers, External Pacemakers), And Segment Forecasts, 2018 – 2025

The global cardiac prosthetic device market size is expected to be over USD 8.7 billion by 2025, based on a new study by Grand View Research, Inc. Rising demand for minimally invasive devices has provided greater growth prospects for the market. New product development through technological advancements is anticipated to foster market growth. The major companies are focusing on expanding their product life and safety benefits of the cardiac prosthetic devices. Such initiatives undertaken by the key players have resulted in increasing survival rates and low stroke rates for transcatheter aortic valves.

Transcatheter aortic valve replacement (TAVR) is covered by Evidence Development (CED) Coverage provided by the Centers for Medicare & Medicaid Services (CMS). Cardiac pacemakers are also covered under Medicare program. Initiatives for reimbursement from the government for such devices are anticipated to boost the demand for cardiac prosthetic devices.

Access Research Report of Cardiac Prosthetic Devices Market @ https://www.grandviewresearch.com/industry-analysis/cardiac-prosthetic-devices-market

Further Key Findings From the Study Suggest:

Heart valve segment was one of the largest segments in 2015 owing to rising prevalence of valvular disease and heart valve failure.
Pacemakers segment is expected to grow significantly, owing to rising reimbursement policies for pacemaker-related surgeries.
Mechanical heart valve segment contributed toward the one of the largest market share in 2015 owing to its increasing product longevity. Moreover, they provide better hemodynamic efficiency. Since mechanical valves are made up of strong durable materials, such as titanium and carbon, they are preferred over other cardiac prosthetic devices.
Transcatheter valve is expected to exhibit lucrative CAGR over the forecast period. TAVR has shown improved patient survival rate as compared to medical therapy. In the past years, it has evolved as a minimally invasive alternative treatment for surgical valve replacement.
Implantable pacemakers are one of the highest revenue generating segments owing to their greater applicability pertaining to heart failure (HF) and other cardiovascular diseases like stroke.
North America contributed toward the largest market share of around 40.0% in 2015. This is primarily due to the fact that the number of pacemaker implantations has increased amongst the Americans over the past two decades. Moreover, companies are focusing on commercial availability of technologically advanced devices in the U.S.
Asia Pacific is anticipated to witness highest CAGR over the forecast period owing to the growing geriatric population in Japan. In 2015, the geriatric population base accounted for around 27% in Japan.
Some key companies in cardiac prosthetic devices market are Medtronic, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Abbott Vascular; Siemens Healthcare GmbH; and Sorin Group.
New product development through introduction of advanced technology and mergers & acquisitions are some of the key strategies adopted by the companies to enhance the demand for cardiac prosthetic devices. For instance, in 2015, St. Jude Medical and Thoratec, a company that specializes in mechanical circulatory support technology for the treatment of advanced HF, entered into a definitive agreement aiming at acquisition of the outstanding shares of Thoratec.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global cardiac prosthetic device market on the basis of product:

Cardiac Prosthetic Device Product Outlook (Market Revenue in USD Million, 2014 – 2025)

Heart valves
- Mechanical valve
- Tissue valve
  - Stented tissue valve
  - Stentless tissue valve
- Transcatheter valve
Pacemakers
- Implantable pacemakers
  - Single-Chamber Battery Pacemaker
  - Dual-Chamber Battery Pacemaker
  - Triple-Chamber Battery Pacemaker
- External pacemakers

Cardiac Prosthetic Device Regional Outlook (Market Revenue in USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Access Press Release of Cardiac Prosthetic Devices Market @ https://www.grandviewresearch.com/press-release/global-cardiac-prosthetic-devices-market

About Grand View Research

For More Information:www.grandviewresearch.com

	knowledgesourcing1 on Modular Instruments Market Exp…
	knowledgesourcing1 on Spirometer Market is Predicted…
	james cofer on Ostomy Care And Accessories Ma…
	violintec on Railway Wiring Harness Market…
	Russel David on HR Analytics Market Projected…

	knowledgesourcing1 on Modular Instruments Market Exp…
	knowledgesourcing1 on Spirometer Market is Predicted…
	james cofer on Ostomy Care And Accessories Ma…
	violintec on Railway Wiring Harness Market…
	Russel David on HR Analytics Market Projected…